Core Viewpoint - Mobix Labs (MOBX) has announced a public offering of 30,000,000 shares of its common stock, aiming for gross proceeds of approximately $6 million, which will be used for working capital and corporate purposes, including growth initiatives and M&A strategy [1] Group 1 - The public offering is expected to close on January 7, 2026, pending customary closing conditions [1] - D. Boral Capital is serving as the Sole Placement Agent for this offering [1] - The net proceeds from the offering will support the company's expansion in military, defense, aerospace, and connectivity markets [1]

Market Overview - U.S. stocks showed mixed performance with the Nasdaq Composite gaining over 50 points, while the Dow decreased by 0.03% to 48,962.01 and the S&P 500 rose by 0.14% to 6,911.52 [1] - Energy shares increased by 2.9%, while utilities stocks fell by 2.2% [1] Company Earnings - AngioDynamics, Inc. reported better-than-expected second-quarter results with an adjusted EPS of $0.00, surpassing market estimates of a loss of $0.10 per share. Sales reached $79.433 million, exceeding expectations of $76.300 million [2] Commodity Prices - Oil prices rose by 0.5% to $58.58, gold increased by 0.6% to $4,477.40, silver gained 2.4% to $78.505, and copper rose by 1.4% to $6.0565 [5] European Market Performance - European shares were mostly higher, with the eurozone's STOXX 600 gaining 0.3%, Spain's IBEX 35 Index rising 0.5%, London's FTSE 100 increasing by 1%, Germany's DAX gaining 0.4%, and France's CAC 40 slipping by 0.3% [6] Asian Market Performance - Asian markets closed mostly higher, with Japan's Nikkei 225 up 1.32%, Hong Kong's Hang Seng Index up 1.38%, China's Shanghai Composite surging 1.50%, while India's BSE Sensex fell by 0.44% [7] Notable Stock Movements - Alumis Inc. shares surged 148% to $20.54 following positive Phase 3 trial results for envudeucitinib in psoriasis [8] - Envirotech Vehicles, Inc. shares rose 73% to $0.6699 after announcing a merger transaction [8] - Cyclerion Therapeutics Inc. shares increased by 54% to $2.13 due to an expanded collaboration with Medsteer [8] - Instil Bio Inc. shares dropped 53% to $5.78 after discontinuing clinical development of AXN-2510 [8] - MOBIX LABS, INC. shares fell 45% to $0.18 following a $6.0 million stock offering [8] - BitVentures Ltd – ADR shares decreased by 23% to $11.40 [8] Economic Indicator - The Logistics Manager's Index declined for the second consecutive month to 54.2 in December, down from 55.7 in the previous two months [9]

Market Overview - U.S. stock futures showed mixed results, with Dow futures declining by 0.2% [1] Company-Specific Movements - Jefferson Capital Inc (NASDAQ:JCAP) experienced a significant drop of 4.4%, trading at $22.00, following the announcement of a secondary offering of 10 million shares [1] - MOBIX LABS, INC. (NASDAQ:MOBX) fell sharply by 25.4% to $0.24 due to plans for a common stock offering [2] - Datavault AI Inc (NASDAQ:DVLT) shares decreased by 12.4% to $1.26 after a previous surge of 43% on Monday, linked to a nationwide deployment announcement [2] - BitVentures Ltd – ADR (NASDAQ:BVC) saw a decline of 9.7% to $13.33 after a 5% gain on Monday [2] - Zenas Biopharma Inc (NASDAQ:ZBIO) tumbled by 6.6% to $15.50 following a 52% drop on Monday due to Phase 3 trial results [2] - Theravance Biopharma Inc (NASDAQ:TBPH) dipped 6% to $17.07 after a 3% decline on Friday [2] - Graphic Packaging Holding Co (NYSE:GPK) fell 4.9% to $14.70 ahead of its fourth quarter financial results announcement [2] - ATRenew Inc (NYSE:RERE) declined by 4.1% to $5.65 after a 9% gain on Monday [2] - Rezolve AI PLC (NASDAQ:RZLV) fell 3.7% to $3.07 in pre-market trading [2] - NovaBay Pharmaceuticals Inc (NYSE:NBY) slipped 3.4% to $6.52 after a 15% jump on Monday [2] - Starfighters Space Inc (NYSE:FJET) decreased by 3.3% to $9.08 after a 10% dip on Monday [2]

Core Viewpoint - Mobix Labs, Inc. has announced a public offering of 30,000,000 shares of common stock, aiming for gross proceeds of approximately $6.0 million, which will support its growth initiatives and M&A strategy [1][2][3] Group 1: Offering Details - The public offering is expected to close on January 7, 2026, pending customary closing conditions [1] - D. Boral Capital is acting as the Sole Placement Agent for the offering [2] - The offering is conducted under a "shelf" registration statement on Form S-3, with a preliminary prospectus supplement filed with the SEC [3] Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital and general corporate purposes, including accelerating growth initiatives and advancing M&A strategies [2][3] - The company aims to expand its technology portfolio and enhance its capabilities in military, defense, aerospace, and connectivity markets [2][6] Group 3: Company Overview - Mobix Labs designs and develops advanced connectivity solutions, including RF, switching, and EMI filtering technologies, targeting various sectors such as defense and aerospace [6] - The company plans to pursue acquisitions of revenue-generating companies to enhance its product offerings and expand into strategically aligned industries [6]

Core Viewpoint - Mobix Labs, Inc. plans to conduct a public offering of its common stock to raise funds for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The public offering will consist of shares of common stock or equivalents, all of which will be sold by the Company [1]. - The offering is subject to market conditions, and there is no assurance regarding its completion or the terms [1]. - D. Boral Capital is acting as the Sole Placement Agent for the offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital and general corporate purposes [2]. Group 3: Regulatory Information - The securities are being offered under a "shelf" registration statement on Form S-3, which was declared effective by the SEC on January 24, 2025 [3]. - A preliminary prospectus supplement will be filed with the SEC and will be available on its website [3]. Group 4: Company Overview - Mobix Labs designs and sells components and systems for advanced connectivity solutions, including RF and EMI filtering technologies [5]. - The Company targets various markets such as defense, aerospace, commercial, and industrial sectors [5]. - Mobix Labs aims to enhance its product portfolio through acquisitions of companies with existing revenue and scalable technologies [5].

Core Viewpoint - Mobix Labs is expanding its defense manufacturing capabilities by transitioning to a larger, military-approved facility and appointing Amir Asvadi as General Manager to lead its EMI product line and defense operations [1][4][6] Group 1: Leadership and Management - Amir Asvadi has been appointed as General Manager, bringing extensive experience in defense and aerospace markets, having previously held senior leadership roles in publicly traded companies [3][4] - The CEO of Mobix Labs, Phil Sansone, emphasized Asvadi's operational focus and leadership experience as crucial for executing the company's expansion plans effectively [4][6] Group 2: Facility Expansion - Mobix Labs plans to move into a larger, military-approved facility to consolidate its West Coast operations, which aims to streamline production and improve operational efficiency [4][5] - The expansion is seen as a vital step to increase throughput and enhance responsiveness for customers who depend on reliable production and delivery [5][6] Group 3: Market Position and Demand - Mobix Labs supports critical defense applications, with its EMI product line being integral to various military platforms, including the US F-35 Lightning and Apache Helicopter [2][6] - The company is experiencing continued momentum in the defense and aerospace sectors, where there is a growing demand for secure, high-reliability technologies [6][7]

Core Viewpoint - Mobix Labs is expected to achieve a 54% year-over-year revenue growth for fiscal year 2025, alongside significant gross margin expansion and reduced operating losses [1][5]. Financial Highlights - Total net revenue for fiscal 2025 is projected to be between $9.7 million and $9.9 million, compared to $6.4 million in fiscal 2024, indicating a growth of approximately 54% year-over-year [5]. - Gross margin for fiscal 2025 is anticipated to be in the range of 50.2% to 50.5%, an increase from 39.6% in fiscal 2024, reflecting an improvement of about 10.6 percentage points [5]. - GAAP loss from operations for fiscal 2025 is expected to be between $37.7 million and $37.8 million, a decrease from $46.4 million in fiscal 2024 [5]. - For the fourth quarter of fiscal 2025, GAAP loss from operations is projected to be between $7.2 million and $7.3 million, down from $11.2 million in the fourth quarter of fiscal 2024 [5]. - Adjusted loss from operations for fiscal 2025 is expected to be in the range of $8.5 million to $8.6 million, compared to $16.0 million in fiscal 2024, representing an improvement of approximately 47% [5]. - Adjusted loss from operations for the fourth quarter of fiscal 2025 is anticipated to be between $1.3 million and $1.4 million, down from $3.6 million in the fourth quarter of fiscal 2024 [5]. - Cash and cash equivalents are expected to be between $3.1 million and $3.3 million as of September 30, 2025, compared to $0.2 million as of June 30, 2025, and $0.3 million as of September 30, 2024 [5]. Liquidity Position - The company believes that its year-end cash balance, along with anticipated cash flows and available financing arrangements, provides an improved liquidity position as it continues to execute its operating plan [4].

Group 1 - Mobix Labs, Inc. has taken a strategic minority stake in TalkingHeads Wireless, expanding into AI infrastructure and deepening an existing partnership [1][2] - The investment aims to enhance efficiency in AI-era wireless networks through THW's AI-driven power management and Mobix's RF engineering, targeting energy savings at the base-station level [2][3] - The collaboration is positioned as a fast entry into the AI infrastructure ecosystem, focusing on AI-enabled, energy-efficient base-station technology [2][3] Group 2 - The market demand for AI-driven efficiency in wireless communications is highlighted as a rapidly growing opportunity, with Mobix's strategy to commercialize alongside THW [3] - Mobix Labs is identified as a fabless semiconductor and connectivity company, specializing in high-performance RF, optical, and mixed-signal solutions for various markets, including communications and emerging AI infrastructure [4]

Core Viewpoint - Mobix Labs, Inc. anticipates significant improvements in financial performance for fiscal year 2025, including increased revenue and reduced operational losses [1][5]. Financial Highlights - Total net revenue for fiscal 2025 is expected to be between $9.7 million and $9.9 million, representing an increase of approximately 54% compared to $6.4 million in fiscal 2024 [5]. - Gross margin for fiscal 2025 is projected to be in the range of 50.2% to 50.5%, an improvement of approximately 10.6% from 39.6% in fiscal 2024 [5]. - GAAP loss from operations for fiscal 2025 is expected to be between $37.7 million and $37.8 million, down from $46.4 million in fiscal 2024 [5]. - For the fourth quarter of 2025, GAAP loss from operations is anticipated to be in the range of $7.2 million to $7.3 million, compared to $11.2 million in the fourth quarter of 2024 [5]. - Adjusted loss from operations for fiscal 2025 is expected to be between $8.5 million and $8.6 million, a 47% improvement from $16.0 million in fiscal 2024 [5]. - Cash and cash equivalents are projected to be between $3.1 million and $3.3 million as of September 30, 2025, a significant increase from $0.2 million as of June 30, 2025, and $0.3 million as of September 30, 2024 [5]. Liquidity Position - The company believes that its year-end cash balance, along with anticipated cash flows and available financing arrangements, provides an improved liquidity position as it executes its operating plan [4]. Use of Non-GAAP Financial Measures - The company utilizes non-GAAP financial measures to provide additional transparency into business trends, which include Adjusted Gross Profit and Adjusted Loss from Operations [6][7]. - These non-GAAP measures are intended to complement GAAP measures and help in understanding the company's ongoing operations and financial performance [8]. Future Reporting - Final results will be reported in the company's Annual Report on Form 10-K for the year ended September 30, 2025, which will include reconciliations of non-GAAP measures to GAAP measures [9].

Core Insights - Nova is significantly outperforming Mobix Labs across various financial metrics, indicating a stronger business position overall [10] Profitability - Nova has a net margin of 29.10%, return on equity of 24.36%, and return on assets of 16.66% - In contrast, Mobix Labs shows a net margin of -381.82%, return on equity of -5,149.05%, and return on assets of -113.77% [2] Volatility & Risk - Nova has a beta of 1.79, indicating its stock is 79% more volatile than the S&P 500 - Mobix Labs has a beta of -0.14, suggesting its stock is 114% less volatile than the S&P 500 [3] Analyst Ratings - Nova has no sell ratings, 2 hold ratings, 5 buy ratings, and a rating score of 2.71 - Mobix Labs has 1 sell rating and a rating score of 1.00, indicating a less favorable outlook [5][6] Institutional and Insider Ownership - 83.0% of Nova shares are held by institutional investors, while only 8.6% of Mobix Labs shares are held by institutional investors - 1.0% of Nova shares are held by company insiders compared to 32.0% for Mobix Labs [7] Earnings & Valuation - Nova's gross revenue is $852.72 million with a price/sales ratio of 9.67, while Mobix Labs has gross revenue of $6.44 million with a price/sales ratio of 4.33 - Nova's net income is $183.76 million with earnings per share of $7.65, whereas Mobix Labs has a net loss of $20.03 million and earnings per share of -$1.10 [9]